The treatment of acquired cobalamin deficiency in infants may result in the
development of a syndrome defined by temporary involuntary myoclonic movem
ents. A patient with an inborn error of metabolism resulting in transcobalm
in 2 deficiency who was treated with cobalamin and then developed this synd
rome is presented. Neurologic Investigations were normal. The continuance o
f cobalamin and avoidance of antiepileptic drugs is recommended, To our kno
wledge this is the first such case. (C) 2001 by Elsevier Science Inc. All r
ights reserved.